1 |
Brock, G. B., McMahon, C. G., Chen, K. K., Costigan, T., Shen, W., Watkins, V., Anglin, G. and Whitaker II, S. : Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J. Urol. 168, 1332 (2002).
DOI
ScienceOn
|
2 |
Kloner, R. A., Hutter, A. M., Emmick, J. T., Mitchel, M. I., Denne, J. and Jackson, G. : Time course of the interaction between tadalafil and nitrates. J. Am. Coll. Cardiol. 42, 1855 (2003).
DOI
ScienceOn
|
3 |
식품위생법 제6조(기준.규격이 고시되지 아니한 화학적 합성품 등의 판매 등 금지).
|
4 |
장재희, 박건상, 박혜경, 구용의, 최윤주, 황인경, 김대병 : 식품 중 불법 함유된 발기부전치료제 성분 검출을 위한 동시분석법 연구. 한국식품위생안전성학회지 18, 195 (2003).
과학기술학회마을
|
5 |
Graz, S. R., Flurer, C. L. and Wolnik, K. A. : Analysis of undeclared synthetic phosphodiesterase-5 inhibitors in dietary supplements and herbal matrices by LC-ESI-MS and LC-UV. J. Pharm. Biomed. Anal. 36, 525 (2004).
DOI
ScienceOn
|
6 |
식품 중 부정유해물질분석 매뉴얼 (행정간행물등록번호 11- 1470000-00839-14), 식품의약품안전청 (2005).
|
7 |
Laboratoires Glaxo S. A., France, Tetracyclic Derivatives, Process of Preparation and Use, WO 95/19978 (July 27, 1995).
|
8 |
Lilly Icos LLC, Chemical Compounds, WO 02/00656 A2 (Jan. 3, 2002).
|